S100A8 and acute myeloid leukemia: S100A8 leads to a dissociation of Beclin 1 (BECN1)–BCL-2 complex, which activates autophagy and inhibits apoptosis, inducing arsenic trioxide and vincristine resistance in AML cell lines.